梅州地区小儿支原体肺炎135例分析

Analysis on 135 cases of mycoplasma pneumonia children of Meizhou region

目的:进一步了解小儿支原体肺炎(MP)的发病情况,提高对小儿支原体肺炎的临床表现、并发症、诊断及治疗的认识.方法:对135例支原体肺炎患儿进行回顾性分析,并对红霉素加阿奇霉素序贯治疗及单用阿奇霉素两种治疗方法进行比较.结果:3～6岁儿童支原体肺炎发病占36.3%,婴幼儿占28.4%,6岁儿童支原体肺炎发病占全部病例的57.4%,表明MP在婴幼儿肺炎中并非少见,两种治疗方法疗效无显著差异(P＞0.01),但单用阿奇霉素治疗起效快,安全性及病人的耐受性、依从性好.结论:MP发病率有上升趋势,好发年龄明显提前,症状表现不典型,病程迁延,肺外并发症多见;阿奇霉素可作为治疗的首选药物.

Objective： To further understand the incidence of mycoplasma pneumonia （MP） in children and to know better about the clinical manifestation, complications, diagnosis and treatment of Mp. Methods： Aretrospective study was performed in 135 cases diagnosed as MP among 516 cases with pneumonia received treatment at the same period, and a comparison was made between treatment with both erythromycin and azithromycin and treatment only with azithromycin. Results： The rate of incidence of MP in children of 3 to 6 years old is 36. 3, of infants 28. 4%. The incidence of MP in children of 6 years old constitute 57. 4% of all cases. This result shows a frequent incidence of MP in infants. Two kinds of treatment share no visible difference （ P 〉 0. 01 ）. However, the treatment only with az ithromycin is more effective and much safer, and the patient has better tolerance and compliance. Conclusion： The rate of incidence of MP tends to rise and it＇s apparent that the age for incidence has shifted earlier. The manifestation of such symptom is not typical and the cause of disease delays, which causes usual complications. In consideration of these characteristics of Mp, azithromycin can be the first choice for treatment.